Filter your results
- 2
- 2
- 2
- 1
- 1
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseasesBMC Medicine, 2021, 19 (1), pp.39. ⟨10.1186/s12916-021-01917-6⟩
Journal articles
inserm-03312716v1
|
||
|
Management of NAFLD in primary care settingsLiver International, 2022, 42 (11), pp.2377 - 2389. ⟨10.1111/liv.15404⟩
Journal articles
inserm-04051853v1
|